Metabolomics and preterm birth: What biomarkers in cervicovaginal secretions are predictive of high-risk pregnant women?
Authors:
- Christiane Auray-BlaisCAChristiane Auray-Blais
- Evelyne RaicheEREvelyne Raiche
- René GagnonRGRené Gagnon
- Maryse BerthiaumeMBMaryse Berthiaume
- Jean-Charles PasquierJPJean-Charles Pasquier
- 1 October 2011
- journal article
- Published by Elsevier in International Journal of Mass Spectrometry
- Vol. 307 (1-3) , 33-38
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Metabolomics: biomarkers of disease and drug toxicityArchives of Toxicology, 2010
- The role of metabolites and metabolomics in clinically applicable biomarkers of diseaseArchives of Toxicology, 2010
- Inflammatory Cytokines and Spontaneous Preterm Birth in Asymptomatic WomenObstetrics & Gynecology, 2010
- Metabolomics in premature labor: a novel approach to identify patients at risk for preterm deliveryThe Journal of Maternal-Fetal & Neonatal Medicine, 2010
- Biomarkers in fabry diseaseClinical Therapeutics, 2009
- Prediction of Preterm Birth: Cervical SonographySeminars in Perinatology, 2009
- An overview of proteomic and metabolomic technologies and their application to pregnancy researchBJOG: An International Journal of Obstetrics & Gynaecology, 2008
- Application of Metabolomics to Cardiovascular Biomarker and Pathway DiscoveryJACC, 2008
- Epidemiology and causes of preterm birthThe Lancet, 2008
- Establishing Reporting Standards for Metabolomic and Metabonomic Studies: A Call for ParticipationOMICS: A Journal of Integrative Biology, 2006